142 related articles for article (PubMed ID: 26642048)
1. Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease.
Sass LA; Hair PS; Perkins AM; Shah TA; Krishna NK; Cunnion KM
PLoS One; 2015; 10(12):e0144723. PubMed ID: 26642048
[TBL] [Abstract][Full Text] [Related]
2. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
4. Activated complement in the sputum from patients with cystic fibrosis.
Schiøtz PO; Sørensen H; Høiby M
Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
[TBL] [Abstract][Full Text] [Related]
5. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
7. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
8. A bacterial stimulation assay for bronchoalveolar lavage immune cells from young children with cystic fibrosis.
Liu H; Sarkar S; Azzopardi K; Day S; Yeow S; Ranganathan S; Sutton P;
Scand J Immunol; 2021 Jul; 94(1):e13040. PubMed ID: 33759233
[TBL] [Abstract][Full Text] [Related]
9. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection.
Schiøtz PO; Nielsen H; Høiby N; Glikmann G; Svehag SE
Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):37-40. PubMed ID: 707104
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
11. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.
Hector A; Schäfer H; Pöschel S; Fischer A; Fritzsching B; Ralhan A; Carevic M; Öz H; Zundel S; Hogardt M; Bakele M; Rieber N; Riethmueller J; Graepler-Mainka U; Stahl M; Bender A; Frick JS; Mall M; Hartl D
Am J Respir Crit Care Med; 2015 Apr; 191(8):914-23. PubMed ID: 25632992
[TBL] [Abstract][Full Text] [Related]
19.
Mateu-Borrás M; González-Alsina A; Doménech-Sánchez A; Querol-García J; Fernández FJ; Vega MC; Albertí S
Virulence; 2022 Dec; 13(1):215-224. PubMed ID: 35094639
[TBL] [Abstract][Full Text] [Related]
20. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]